CagriSema
Cagrilintide + Semaglutide combination
≥ 99.0% (component-wise for blends)CAS (blend — components have individual CAS numbers)Custom Blends & OEM
Overview
CagriSema is a combination of the long-acting amylin analog Cagrilintide and the GLP-1 agonist Semaglutide, studied in metabolic and weight-management research. Component ratios are configurable; confirm per batch label.
Specifications
- CAS
- (blend — components have individual CAS numbers)
- Purity (HPLC)
- ≥ 99.0% (component-wise for blends)
- Common vial sizes
- 5 mg, 10 mg, 20 mg
- MOQ
- On request
- Lead time
- 14–21 days
- Storage
- -20°C, protect from light
Documentation available on request
- Certificate of Analysis (COA)
- HPLC Chromatogram
- Mass-spec spectrum
- Stability data
- SDS / MSDS
- Sequence verification
Related peptides